Chemical mechanisms of histone lysine and arginine modifications
about
Clinical and experimental applications of sodium phenylbutyrateDesign of small molecule epigenetic modulatorsTrials with 'epigenetic' drugs: an updateStructural Biology of Human H3K9 MethyltransferasesCrystal Structure of the Plant Epigenetic Protein Arginine Methyltransferase 10Catalytic and functional roles of conserved amino acids in the SET domain of the S. cerevisiae lysine methyltransferase Set1Epigenetic polypharmacology: from combination therapy to multitargeted drugsThe emerging role of lysine methyltransferase SETD8 in human diseasesMultiple levels of epigenetic control for bone biology and pathologyEpigenetic regulation of endothelial-cell-mediated vascular repairA novel mammalian flavin-dependent histone demethylaseETO family protein Mtgr1 mediates Prdm14 functions in stem cell maintenance and primordial germ cell formationEpigenetics and psychoneuroimmunology: mechanisms and modelsCell signaling, post-translational protein modifications and NMR spectroscopyAn alternative mechanism for the methylation of phosphoethanolamine catalyzed by Plasmodium falciparum phosphoethanolamine methyltransferase.A method for systematic mapping of protein lysine methylation identifies functions for HP1β in DNA damage response.Coordinated chromatin control: structural and functional linkage of DNA and histone methylation.Role of HDAC3 on p53 expression and apoptosis in T cells of patients with multiple sclerosis.Vascular histone deacetylation by pharmacological HDAC inhibition.Efficient hit-finding approaches for histone methyltransferases: the key parameters.Small molecule inhibitors of histone acetyltransferases as epigenetic tools and drug candidates.What can we learn about cardioprotection from the cardiac mitochondrial proteome?PLMLA: prediction of lysine methylation and lysine acetylation by combining multiple features.SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins that connect mitochondrial metabolism and carcinogenesis.EZH2: biology, disease, and structure-based drug discoveryEpigenetic drugs against cancer: an evolving landscape.Identification of small-molecule enhancers of arginine methylation catalyzed by coactivator-associated arginine methyltransferase 1.The effect of N-acetylation and N-methylation of lysine residue of Tat peptide on its interaction with HIV-1 TAR RNA.Energizing Genetics and Epi-genetics: Role in the Regulation of Mitochondrial Function.The redox basis of epigenetic modifications: from mechanisms to functional consequences.Biological targets and mechanisms of action of natural products from marine cyanobacteria.Discriminating between lysine sumoylation and lysine acetylation using mRMR feature selection and analysis.Potential non-oncological applications of histone deacetylase inhibitors.Regulation by polycomb and trithorax group proteins in Arabidopsis.Energetics, epigenetics, mitochondrial genetics.Bioorthogonal profiling of protein methylation using azido derivative of S-adenosyl-L-methionine.As(III) S-adenosylmethionine methyltransferases and other arsenic binding proteinsSe-adenosyl-L-selenomethionine cofactor analogue as a reporter of protein methylation.Autoacetylation of the MYST lysine acetyltransferase MOF proteinFacile synthesis and altered ionization efficiency of diverse Nε-alkyllysine-containing peptides
P2860
Q24613511-79851544-D3DD-400F-AAFE-C300CA22D2CCQ26850027-138C4B77-AA66-4B2F-A505-237FB5AA243FQ27000542-AF8D5919-AD49-4C22-8CA8-B12C2B397E76Q27659033-20668EAC-44AF-4651-BE60-D95973A776EFQ27674910-3A4F60DB-371D-402F-9E00-7EC1DD0AD840Q27935081-4F56AADA-0EDF-4324-857F-FB6050A689D6Q28067666-9843ED0A-56E8-4C65-A235-4F791A39AC30Q28079964-1ABBBCA4-83CC-4AE5-9D34-E8886D516412Q28083715-2672F92A-EC6F-40E6-A3BF-94FBFAC8A4FEQ28085420-0D418BD3-161E-4F6D-B894-12D63976BF94Q28587686-E88041DA-7490-424A-AD78-1E8CA39A481DQ28589379-4A0A4109-162E-4FAB-8A54-9C0F2E27D9EEQ28748164-9B65AA9C-4C69-4957-AA93-EBDC60277819Q28830783-BB288B38-A92B-4F45-B349-31B7B5848F44Q30367523-E282B835-2DF6-436B-80B1-7136CF4E1C2FQ33656610-494BAFED-DEA5-439D-9537-6A4EE623C7D3Q33802703-57DA2927-27BB-4149-9336-DCAB59ADCBB8Q33828002-4CD91173-A0AC-4969-A245-C8C498A7E343Q33994818-97E55704-2F14-474A-8431-61CC6E7B2086Q34046987-2A31F992-A739-4C2A-9F69-F598B4916294Q34123380-45CE8FE0-D6C2-4BAD-99D0-341B6FBF392DQ34187849-0634DDEA-2C95-4BA3-9B82-2452CA94246AQ34259740-DEFE02D6-BD01-4182-A602-39301892E90EQ34373638-81D3B524-C04E-4DC6-80DC-71036D7DE296Q34393753-4F1B0279-E75B-45A7-9CA9-03C7ADA70D0BQ34431964-C1183D28-E156-41C3-B1BF-1D4F2EF1AA11Q34456824-83FDDFA1-510E-4AF7-A178-7D22F78862CEQ35023253-9FB0A62E-695A-451E-B747-15FFB954C46BQ35029938-25B85871-16D6-465C-89D4-839E0DF98F5EQ35055739-290EA92C-4687-44A4-9ECD-BD44F80CE23DQ35130835-19F32EB2-3E7D-472E-A9BD-E19864E12B6DQ35253001-7A56479E-A77C-4A2B-AD1A-772879A6569AQ35485587-EF1683DA-F69B-446C-AB16-59FECC7D2D4CQ35630571-ABE1D127-2DF1-428D-AB9F-E39FAA1844D2Q35632855-440BA5B4-EEE2-4CAC-B911-068098FC1CBBQ35912065-E5446E8D-0005-48B1-84B0-0B79E99DE7E2Q36042152-7190E25B-0D3A-4620-8A64-4716C5CCF27AQ36279768-73F85507-F007-4FF2-AEAC-6F3F881DDDBFQ36318753-F37B66F7-9589-4003-9750-945ACF68B08BQ36613455-0622B03A-7235-4F93-9C0E-F0D624456B86
P2860
Chemical mechanisms of histone lysine and arginine modifications
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemical mechanisms of histone lysine and arginine modifications
@en
Chemical mechanisms of histone lysine and arginine modifications.
@nl
type
label
Chemical mechanisms of histone lysine and arginine modifications
@en
Chemical mechanisms of histone lysine and arginine modifications.
@nl
prefLabel
Chemical mechanisms of histone lysine and arginine modifications
@en
Chemical mechanisms of histone lysine and arginine modifications.
@nl
P2860
P1476
Chemical mechanisms of histone lysine and arginine modifications
@en
P2093
Brian C Smith
John M Denu
P2860
P356
10.1016/J.BBAGRM.2008.06.005
P407
P577
2008-06-14T00:00:00Z